Alexander Sparre-Ulrich

Alexander Sparre-Ulrich began their career in 2011 as a PhD student at the University of Copenhagen. In 2015, they took on a role as a Consultant at HERAX. In 2016, they returned to the University of Copenhagen as a Postdoc. In 2017, they became the Co-founder and CEO of Antag Therapeutics. Finally, in 2019, they took on the position of Assistant Professor at the University of Copenhagen.

Alexander Sparre-Ulrich has a diverse educational background. Alexander attended Bornholms gymnasium, followed by Københavns Universitet - University of Copenhagen where they obtained a Bachelor's degree in Biology in 2007, a Master's degree in Human Biology in 2011, and a Doctor of Philosophy (Ph.D.) in Drug discovery and development in 2015. In 2018, they completed the Innovation Leadership and Strategy - Making Innovation Happen program at INSEAD. Additionally, they hold certifications in Advanced Business Development Course from EBD Academy (2021), Prince2 Practitioner Certificate in Project Management from AXELOS Global Best Practice (2016), PRINCE2 Foundation Course from Management Plaza (2015), and PRINCE2 Practitioner Course from Management Plaza.